Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.31 |
| ▸ | TERT | O14746 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carnosine SCHEMBL719517 | 0.97 | CYP3A4 (0.33) | CYP3A4CYP2D6TSHRCYP2C19LMNA | |
| SCHEMBL2319309 | 0.87 | PARP1 (0.38) | CYP3A4CYP2D6TSHRCYP2C19LMNA | |
| Carnosine SCHEMBL1161010 | 0.87 | ITGB3 (0.41) | ITGB3ITGA2BSLC15A2 | |
| Carnosine SCHEMBL3904964 | 0.87 | ITGB3 (0.41) | ITGB3ITGA2BSLC15A2 | |
| Carnosine SCHEMBL33769 | 0.87 | ITGB3 (0.41) | ITGB3ITGA2BSLC15A2 | |
| Carnosine SCHEMBL33768 | 0.87 | ITGB3 (0.41) | ITGB3ITGA2BSLC15A2 | |
| SCHEMBL4588256 | 0.87 | SLC15A2 (0.36) | SLC15A2 | |
| SCHEMBL2811070 | 0.87 | SLC15A2 (0.36) | SLC15A2 | |
| Carnosine SCHEMBL1641133 | 0.86 | ITGB3 (0.40) | ITGB3ITGA2BSLC15A2 | |
| Carnosine SCHEMBL308693 | 0.86 | ITGB3 (0.40) | ITGB3ITGA2BSLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080114065-A1 | Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology | BIONEXUS, LTD. | 2008-05-15 | — | — | US | disclosed |